Phenyl-Mobuzon en es it fr

Phenyl-Mobuzon Brand names, Phenyl-Mobuzon Analogs

Phenyl-Mobuzon Brand Names Mixture

  • Alka Phenyl Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
  • Alka Phenylbutazone Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
  • Phenylone Plus Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)

Phenyl-Mobuzon Chemical_Formula


Phenyl-Mobuzon RX_link

No information avaliable

Phenyl-Mobuzon fda sheet

Phenyl-Mobuzon msds (material safety sheet)

Phenyl-Mobuzon MSDS

Phenyl-Mobuzon Synthesis Reference

Ullmann's Encyklopaedie der Technischen Chemie 13, 298 (1962)

Phenyl-Mobuzon Molecular Weight

308.374 g/mol

Phenyl-Mobuzon Melting Point

105 oC

Phenyl-Mobuzon H2O Solubility

47.5 mg/L

Phenyl-Mobuzon State


Phenyl-Mobuzon LogP


Phenyl-Mobuzon Dosage Forms

Bolus; Liquid; Paste; Powder; Solution; Tablet

Phenyl-Mobuzon Indication

For the treatment of backache and ankylosing spondylitis

Phenyl-Mobuzon Pharmacology

Phenylbutazone is a synthetic, pyrazolone derivative. It is a nonhormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties and arise from its ability to reduce production of prostaglandin H and prostacyclin. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostacylcin causes vascular constriction platelet disaggregation

Phenyl-Mobuzon Absorption

No information avaliable

Phenyl-Mobuzon side effects and Toxicity

Oral, LD50 = 238 mg/kg (mouse); Oral, LD50 = 781 mg/kg (rabbit); Oral, LD50 = 245 mg/kg (rat); Oral, LD50 = 375 mg/kg (rat)

Phenyl-Mobuzon Patient Information

No information avaliable

Phenyl-Mobuzon Organisms Affected

Humans and other mammals